ATE71459T1 - Verfahren zur ueberwachung der blutgerinnung. - Google Patents

Verfahren zur ueberwachung der blutgerinnung.

Info

Publication number
ATE71459T1
ATE71459T1 AT85307426T AT85307426T ATE71459T1 AT E71459 T1 ATE71459 T1 AT E71459T1 AT 85307426 T AT85307426 T AT 85307426T AT 85307426 T AT85307426 T AT 85307426T AT E71459 T1 ATE71459 T1 AT E71459T1
Authority
AT
Austria
Prior art keywords
vmax
coagling
procedure
monitoring blood
time
Prior art date
Application number
AT85307426T
Other languages
English (en)
Inventor
Myatt S Lipscomb
Original Assignee
Ortho Diagnostic Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Diagnostic Systems Inc filed Critical Ortho Diagnostic Systems Inc
Application granted granted Critical
Publication of ATE71459T1 publication Critical patent/ATE71459T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/4905—Determining clotting time of blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N21/82—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a precipitate or turbidity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Ecology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plasma & Fusion (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Paper (AREA)
  • Investigating Or Analyzing Materials Using Thermal Means (AREA)
AT85307426T 1984-10-15 1985-10-15 Verfahren zur ueberwachung der blutgerinnung. ATE71459T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848426004A GB8426004D0 (en) 1984-10-15 1984-10-15 Coagulation monitoring
EP85307426A EP0178910B1 (de) 1984-10-15 1985-10-15 Verfahren zur Überwachung der Blutgerinnung

Publications (1)

Publication Number Publication Date
ATE71459T1 true ATE71459T1 (de) 1992-01-15

Family

ID=10568202

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85307426T ATE71459T1 (de) 1984-10-15 1985-10-15 Verfahren zur ueberwachung der blutgerinnung.

Country Status (9)

Country Link
US (1) US4720787A (de)
EP (1) EP0178910B1 (de)
JP (2) JPH0782020B2 (de)
AT (1) ATE71459T1 (de)
AU (1) AU591465B2 (de)
CA (1) CA1236921A (de)
DE (1) DE3585129D1 (de)
ES (1) ES8704637A1 (de)
GB (1) GB8426004D0 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4794450A (en) * 1986-08-29 1988-12-27 Fujirebio Kabushiki Kaisha Method and apparatus for judging agglutination pattern
US5759774A (en) * 1988-05-18 1998-06-02 Cobe Laboratories, Inc. Method of detecting circulating antibody types using dried or lyophilized cells
EP0482088B1 (de) * 1989-07-20 1999-03-31 Analytical Control Systems, Inc. Verbesserte kontrollverfahren für stabile blutkoagulation
US5223437A (en) * 1989-12-01 1993-06-29 Akzo N.V. Direct fibrinogen assay
IE904244A1 (en) * 1989-12-01 1991-06-05 Akzo Nv Direct fibrinogen assay
US5169786A (en) * 1989-12-19 1992-12-08 Ortho Diagnostic Systems, Inc. Method of determining levels of extrinsic and intrinsic clotting factors and protein c
US5197017A (en) * 1990-09-27 1993-03-23 Carroll Wallace E Potentiophotometric fibrinogen determination
DE4117583A1 (de) * 1991-05-29 1992-12-03 Helmut Prof Dr Orth Geraet zur messung der blutsenkung
US5416575A (en) * 1991-11-18 1995-05-16 Schwartz; Mark Method and system for calibrating an optical density measurement apparatus
US5522255A (en) * 1993-08-31 1996-06-04 Boehringer Mannheim Corporation Fluid dose, flow and coagulation sensor for medical instrument
US5526111A (en) * 1993-08-31 1996-06-11 Boehringer Mannheim Corporation Method and apparatus for calculating a coagulation characteristic of a sample of blood a blood fraction or a control
US5502651A (en) * 1994-05-02 1996-03-26 Jackson; R. David Potentiophotometric fibrinogen determination
US6221672B1 (en) 1996-04-30 2001-04-24 Medtronic, Inc. Method for determining platelet inhibitor response
DE19629992A1 (de) * 1996-07-25 1998-01-29 Manfred Dr Winkler Verfahren und Einrichtung zur Bestimmung der Extinktion einer Lichtstrahlung beim Durchdringen einer Probe
US6010911A (en) * 1997-04-30 2000-01-04 Medtronic, Inc. Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique
US5951951A (en) 1997-04-30 1999-09-14 Medtronic, Inc. Platelet function evaluation technique for citrated whole blood
EP0932041A3 (de) * 1998-01-23 2000-08-30 Medical Laboratory Automation Inc. Blutgerinnungsanalysevorrichtung
JP4235279B2 (ja) * 1998-04-10 2009-03-11 生化学工業株式会社 新規酵素反応測定法
AU8679298A (en) * 1998-07-31 2000-02-21 Wallace E. Carroll Method and apparatus for determining anticoagulant therapy factors
US6524861B1 (en) 1999-01-22 2003-02-25 Medical Laboratory Automation, Inc. Blood coagulation analyzer
US6706536B1 (en) 2000-11-28 2004-03-16 Wada, Inc. Method and apparatus for processing coagulation studies, chemistry procedures and the like
US7010432B2 (en) * 2002-08-30 2006-03-07 Lifescan, Inc. Method and system for determining the acceptability of signal data collected from a prothrombin time test strip
US7276377B2 (en) * 2003-05-02 2007-10-02 Wada, Inc. Method and apparatus for determining anticoagulant therapy factors
US20040219680A1 (en) * 2003-05-02 2004-11-04 Carroll Wallace E. Method and apparatus for determining anticoagulant therapy factors
US7901694B2 (en) * 2003-05-02 2011-03-08 Carroll Wallace E Method and apparatus for determining anticoagulant therapy factors
EP1747451B1 (de) * 2004-05-17 2011-11-02 Medtronic, Inc. Point-of-care-heparinbestimmungssystem
US20080081980A1 (en) * 2006-09-18 2008-04-03 Michael Maschke Apparatus and process for stroke examination and treatment using a C-arch X-ray system
US8445287B2 (en) * 2009-02-14 2013-05-21 Wada, Inc. Method and apparatus for determining anticoagulant therapy factors
JP6073117B2 (ja) * 2012-11-26 2017-02-01 株式会社日立ハイテクノロジーズ 自動分析装置、自動分析方法
CN105102988B (zh) * 2013-04-02 2017-03-08 株式会社日立高新技术 自动分析装置以及分析方法
JP6563681B2 (ja) * 2015-05-08 2019-08-21 シスメックス株式会社 検体分析装置、血液凝固分析装置、検体分析方法、及びコンピュータプログラム
EP3225998A1 (de) * 2016-03-31 2017-10-04 Siemens Healthcare Diagnostics Products GmbH Verfahren zur bestimmung von fibrinogen
EP4239078A4 (de) * 2020-10-29 2024-09-18 Sekisui Medical Co., Ltd. Verfahren zum nachweis einer blutgerinnungsreaktion

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3458287A (en) * 1965-04-29 1969-07-29 Medical Laboratory Automation Method and means of determining endpoint times in blood clotting tests
US3674012A (en) * 1970-04-17 1972-07-04 American Optical Corp Blood coagulation detection device
US4047890A (en) * 1973-11-01 1977-09-13 Bio/Data Corporation Method and apparatus for determining deficiencies in enzymatic reactors particularly clotting factor levels in blood plasmas
DE2635081C3 (de) * 1976-08-04 1980-08-07 Bio/Data Corp., Willow Grove, Pa. (V.St.A.) Verfahren und Vorrichtung zur Bestimmung von Blutplasma-Gerinnungsfaktorpegeln
JPS5451893A (en) * 1977-09-30 1979-04-24 Sankyo Co Measuring of blood coagulating time
JPS5469497A (en) * 1977-11-12 1979-06-04 Kyoto Daiichi Kagaku Kk Method and device for measuring blood solidification time
JPS5822703B2 (ja) * 1978-08-30 1983-05-10 三共株式会社 血液凝固測定方法
CA1183367A (en) * 1981-09-24 1985-03-05 Ali H. Eseifan Optical analyzing method and system
DD207128A3 (de) * 1981-12-29 1984-02-15 Guenter Schumann Schaltungsanordnung zur messung und berechnung von parametern eines reaktionsablaufs
DE3311287A1 (de) * 1983-03-28 1984-10-04 Behringwerke Ag, 3550 Marburg Verfahren zur fotometrischen bestimmung der aktivierten partiellen thromboplastinzeit und reagenz dazu
FR2571497B1 (fr) * 1984-10-09 1990-05-11 Toa Medical Electronics Cy Ltd Appareil a mesurer le temps de coagulation du sang

Also Published As

Publication number Publication date
GB8426004D0 (en) 1984-11-21
US4720787A (en) 1988-01-19
JPS61128172A (ja) 1986-06-16
DE3585129D1 (de) 1992-02-20
ES547898A0 (es) 1987-04-01
CA1236921A (en) 1988-05-17
EP0178910A2 (de) 1986-04-23
EP0178910B1 (de) 1992-01-08
JP2500848B2 (ja) 1996-05-29
JPH06230011A (ja) 1994-08-19
ES8704637A1 (es) 1987-04-01
AU4872885A (en) 1986-04-24
EP0178910A3 (en) 1988-11-17
AU591465B2 (en) 1989-12-07
JPH0782020B2 (ja) 1995-09-06

Similar Documents

Publication Publication Date Title
AU591465B2 (en) Methods for coagulation monitoring
DE69018910D1 (de) Verfahren zur Bestimmung des endogenen Thrombinpotentials von Plasma und Blut und Reagenziensatz zur Verwendung in besagtem Verfahren.
ATE35000T1 (de) Reagenz zur bestimmung der thromboplastinzeit.
ES2088992T3 (es) Metodo para determinar los niveles de factores de coagulacion intrinsecos y extrinsecos y proteina c.
EP0632270A4 (de) Verfahren zur bestimmung der aktivität des blutgerinnungsfaktors xiii und reagentiensatz dafür.
ATE315233T1 (de) Verfahren zur bestimmung des antikoagulatorischen potentials einer probe und verfahren zur bestimmung der glykosilierung von thrombomodulin
ATE121139T1 (de) Verfahren zur bestimmung der konzentration von antikoagulantien.
JPH0368680B2 (de)
DE3780485D1 (de) Verfahren zur photometrischen bestimmung der protein c- und/oder protein s-aktivitaet.
ATE22928T1 (de) Verfahren zur bestimmung der wirksamkeit von plasminogen-aktivator des gewebes und zur verwendung in diesem verfahren geeigneter reagenzsatz.
DK0830608T3 (da) Thromboseriskotest
DE68912115D1 (de) Ausscheidungsverfahren für die herstellung von thromboplastinreagenzien.
EP0229234A1 (de) Verfahren zur photometrischen Bestimmung von Protein C
GB1471742A (en) Process for measuring the plasminogen content of a plasma sample
ATE45771T1 (de) Verfahren zur bestimmung des fibrinolytischen zustands von plasma.
ATE218166T1 (de) Verfahren zur reduzierung der beeinflussung von diagnostischen tests durch heparin unter verwendung von metallsalzen und diagnostisches reagenz für diagnostische tests zur bestimmung der gerinnungsfähigkeit des blutes enthaltend metallsalze
Sturk et al. Analytical and clinical evaluation of commercial protein C assays
Becker et al. Automated prothrombin-time test with use of a chromogenic peptide substrate and a centrifugal analyzer.
DE3850346D1 (de) Verfahren zur Selbstdurchführung von Enzymkinetik.
EP0378139A3 (de) Verfahren zur Bestimmung der fibrinolytischen Gesamtaktivität im Plasma
Barson et al. Quantitative one-stage assays for factors V and X
ATE15546T1 (de) Haemolytisches verfahren zur kinetischen bestimmung von antistreptolysin-o-antikoerpern in blut- oder serumproben, unter anwendung von oxydiertem streptolysin-o.
Takahashi et al. Fast functional assay of protein C in whole plasma using a snake venom activator: evaluation in patients with congenital and acquired protein C deficiencies
WO2025186634A8 (en) Method and kit for monitoring anticoagulant therapy
Baele et al. Comparison of a Recombinant Thromboplastin with Thrombotest® for Oral Anticoagulant Control

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time